News About: Pharm. Industry
Fierce competition to be seen for next generation oral anticoagulants
Multinational pharmaceutical companies are stepping up their marketing in the domestic market of oral anticoagulants replacing warfarin as mainstay therapy, which is forecast to become more competitive than even, acco...
Korea eyes $3.2 billion in 2012 drug exports
Korea will seek to sharply increase its export goal for pharmaceutical goods in 2012 through a variety of promotion measures, a trade group said Monday. Pharmaceutical goods include drugs, medical supplies, raw materi...
Pharmaceutical firms fared worse in 1Q
Korea’s major pharmaceutical firms saw their earnings decline 43 percent for the first quarter of this year due to hurried disposal of drug inventories ahead of government-mandated cuts in drug prices in April 1.
A...
Korean drug makers seeking to launch generic version of Viagra
A total of 11 Korean drug companies are poised to leap on the opportunities presented by the soon-to-be expired patent of Viagra (sildenafil citrate) – the first and the most popular prescription drug for Erectile Dys...
Sanofi names new execs in shake-up
The Korean unit of Sanofi-Aventis, one of the world's foremost pharmaceutical companies, yesterday promoted two managing directors as executive managing directors.in a management reshuffle.
The two executives are ...
Generic Viagra makers queue up
As the main patent for Viagra, the world’s bestselling anti-impotence pill, nears its expiration, Korean pharmaceutical companies are gearing up to push generics into the market.
The pharmaceutical unit of CJ Chei...
New KPMA head should be given full power
The Korea Pharmaceutical Manufacturers Association (KPMA) is busy finding eligible candidates for its new head as incumbent president Yoon Suk-geun has stepped out.
However, chairmen from large pharmaceutical compa...
Restructuring hitting multinational drug firms
Foreign invested pharmaceutical firms have been taking steps to reduce their workforces as they brace for lower earnings due to the government’s pressure to reduce drug prices.
Three multinational firms, such as Sa...
4 largest pharmaceutical firms witness 418 percent increase in sales during decade
Korea’s ‘Big Four’ drug makers, such as Dong-A, Daewoong, Green Cross and Yuhan, have seen a whopping sales increase of 418 percent over the past 10 years, according to a report compiled by Yakup.com, a pharmaceutical...
Top 7 drug firms suffer earning decline in first quarter
Korea’s leading pharmaceutical companies saw their operating profit decline in the first quarter of this year on their hurried handling of drug inventories ahead of government-mandated cuts in drug prices, data showed...
